Loading organizations...
§ Private Profile · 201 W California Ave, Sunnyvale, CA 94086
An organization providing custom solutions and services for biological systems, focusing on tailored biotechnology applications.
Key people at Custom Biosystems.
Custom Biosystems was founded in 2003 by Corey Reese (Co-Founder & VP, Business Development).
Custom Biosystems is a private organization presumably operating within the biotechnology or life sciences sector, though its specific commercial activities, core product offerings, and primary headquarters location remain undisclosed at this time. The enterprise has not publicly detailed its overarching business model, target customer demographics, or the specific technological applications it intends to develop for the broader market. Furthermore, standard financial and operational metrics, including total venture funding raised, current corporate valuation, assets under management, and total employee count, are not currently available in public financial databases. There are no publicly disclosed lead investors, institutional venture capital backers, strategic corporate partners, or recognizable enterprise clients associated with the firm's development pipeline. Consequently, comprehensive historical data regarding the organization's exact founding year and the specific identities of its original founding members have not been released to the public.
Key people at Custom Biosystems.
Custom Biosystems was founded in 2003 by Corey Reese (Co-Founder & VP, Business Development).
Custom Biogenic Systems (CBS) is a Michigan-based manufacturer of cryogenic storage solutions for laboratories, specializing in advanced equipment like isothermal freezers using dry liquid nitrogen technology, cryogenic freezers, controlled rate freezers, racks, canisters, and monitoring accessories.[1][2][3] It serves pharmaceutical, biobank, medical, research, and industrial sectors in life sciences by enabling safe, efficient preservation of biological samples.[1][2][3] Founded in 1987, CBS generated an estimated $15 million in revenue in 2024 before its acquisition by Standex International in November 2024 for $6.2 million, marking a pivotal growth milestone as it integrates into a larger scientific products portfolio.[1][2]
CBS was founded in 1987 in Bruce Township (Macomb), Michigan, to meet the demand for reliable cryogenic storage in life sciences, with John Brothers listed as owner.[1][3][4] From its early years, the company emphasized innovation in cryopreservation, developing products like upright and chest freezer racks, liquid nitrogen systems, and inventory tools.[3] Key evolution included breakthroughs in isothermal freezers with dry liquid nitrogen jackets for safer storage, alongside market expansion domestically and internationally over 30+ years, building a reputation for quality and customer service.[3] A defining moment came in November 2024 when Standex acquired CBS, accretive to earnings and expanding its scientific segment.[2]
CBS rides the wave of expanding biobanking, personalized medicine, and biotech R&D, where secure cryogenic storage is critical for preserving cells, tissues, and vaccines amid rising demand for long-term sample integrity.[1][2][3] Timing aligns with post-pandemic growth in life sciences infrastructure, as labs scale for gene therapies and regenerative medicine, favoring reliable, innovative equipment over traditional methods.[3] Market forces like regulatory demands for sample safety and efficiency boost CBS's dry nitrogen tech, which reduces contamination risks.[1][2] Its acquisition by Standex amplifies influence, integrating CBS into a global multi-industry manufacturer to enhance scientific offerings and accelerate adoption in research ecosystems.[2]
Post-acquisition, CBS will leverage Standex's resources for R&D expansion, global distribution, and product integration, potentially driving revenue beyond $15 million through cross-selling in electronics and engineering segments.[2] Trends like AI-driven biobanking, cryo-preservation for organoids, and sustainable cooling will shape its path, with dry nitrogen tech gaining traction for safer, greener labs.[1][3] Expect evolved influence as a Standex pillar, influencing standards in cryogenic innovation and solidifying its legacy from niche leader to scaled life sciences enabler—echoing its founding mission of reliable preservation at the forefront of biotech progress.[2][3]
